Myelodysplastic Syndrome
📧 Sign up to get email alerts when something new happens for Myelodysplastic Syndrome.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML) [Phase 1, Phase 2]
Phase 1/2 trial examining idarubicin + cytarabine with lenalidomide for myelodysplastic syndrome and acute myeloid leukemia has completed wi…
-
CLINICAL_TRIALS trial_result · 2016-03-22Clinical Trial Update: Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia [Phase 2]
A Phase 2 trial investigates adding lenalidomide or vorinostat to azacitidine in higher-risk myelodysplastic syndromes or chronic myelomonoc…
-
CLINICAL_TRIALS trial_result · 2016-03-08Clinical Trial Update: Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients [Phase 1]
Phase I study of CWP232291 in patients with acute myeloid leukemia and related myeloid neoplasms has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-04Clinical Trial Update: Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies [Phase 2]
Phase 2 trial of Brentuximab Vedotin in CD30-positive non-lymphomatous malignancies has completed and results were posted in 2016. The study…
-
CLINICAL_TRIALS trial_result · 2016-02-29Clinical Trial Update: Study of Azacitidine to Evaluate Safety and Effectiveness for Chinese Patients With Higher Risk Myelodysplastic Syndrome [Phase 2]
Phase 2 trial evaluating azacitidine in Chinese patients with higher-risk myelodysplastic syndrome has completed with posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Clofarabine Plus Low-Dose Cytarabine Induction and Decitabine Consolidation in Frontline Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 trial evaluating clofarabine with low-dose cytarabine induction followed by decitabine consolidation in frontline acute myeloid leuk…
-
CLINICAL_TRIALS trial_result · 2016-02-26Clinical Trial Update: Safety and Efficacy of POL6326 for Mobilization/Transplant of Sibling Donor in Patients With Hematologic Malignancies [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety and efficacy of POL6326 for mobilization and transplant in hematologic malignancies has completed…
-
CLINICAL_TRIALS trial_result · 2016-02-23Clinical Trial Update: Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia [Phase 1]
Phase 1 study of Terameprocol (EM-1421) in leukemia was terminated; no efficacy results were reported in this update.
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Study of Dasatinib and All-Trans Retinoic Acid for Relapsed/Refractory and/or Elderly Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome [Phase 1]
This Phase 1 trial studied the combination of dasatinib and all-trans retinoic acid in relapsed/refractory and/or elderly patients with acut…
-
CLINICAL_TRIALS trial_result · 2016-02-01Clinical Trial Update: Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT [NA]
This trial assessed whether rituximab (Rituxan) can prevent EBV-associated lymphoproliferative disorder after T-cell-depleted unrelated or H…
-
CLINICAL_TRIALS trial_result · 2016-01-26Clinical Trial Update: Study of Vidaza (Azacitidine) Versus Support Treatment in Patients With Low Risk Myelodysplastic Syndrome (Low and Intermediate-1 IPSS) Without the 5q Deletion and Transfusion Dependent Anaemia [Phase 2]
Phase 2 study comparing azacitidine (Vidaza) to best supportive care in low-risk myelodysplastic syndrome patients without 5q deletion and w…
-
CLINICAL_TRIALS trial_result · 2016-01-18Clinical Trial Update: Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS [Phase 2]
A Phase 2 clinical trial evaluating lenalidomide with prednisone in low and int-1 risk non-5q myelodysplastic syndrome has completed with re…
-
CLINICAL_TRIALS trial_result · 2016-01-14Clinical Trial Update: Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases [Phase 2]
Phase 2 trial evaluating total body irradiation with fludarabine-based conditioning followed by haploidentical transplantation for hematolog…
-
CLINICAL_TRIALS trial_result · 2015-12-21Clinical Trial Update: Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501) [Phase 3]
Phase 3 clinical trial comparing single versus double umbilical cord blood transplants in children with high-risk leukemia and myelodysplasi…
-
CLINICAL_TRIALS trial_result · 2015-12-10Clinical Trial Update: Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy
A completed clinical trial update assessing structural brain imaging and cognitive function in adult stem cell transplant recipients treated…
-
CLINICAL_TRIALS trial_result · 2015-12-02Clinical Trial Update: Treosulfan-based Conditioning for Transplantation in AML/MDS [Phase 2]
Phase 2 trial evaluating treosulfan-based conditioning for transplantation in acute myeloid leukemia and myelodysplastic syndrome. The study…
-
CLINICAL_TRIALS trial_result · 2015-11-30Clinical Trial Update: Clinical Ex Vivo Expansion of Human Umbilical Cord Blood Stem and Progenitor Cells [Phase 1, Phase 2]
An update on a Phase 1/2 trial evaluating ex vivo expansion of human umbilical cord blood stem and progenitor cells for patients with acute …
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Dose Finding Study of Post-BMT Decitabine Maintenance Treatment in Higher-risk MDS and MDS/AML [Phase 1]
Phase 1 dose-finding study evaluating decitabine maintenance after bone marrow transplant in higher-risk myelodysplastic syndrome and MDS/AM…
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: 5 Day Versus 7 Day Azacitidine in Lower Risk Myelodysplastic Syndrome [Phase 2]
This clinical trial update reports on a Phase 2 study comparing 5-day versus 7-day azacitidine in lower-risk myelodysplastic syndrome. The c…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Study of KB004 in Subjects With Hematologic Malignancies (Myelodysplastic Syndrome, MDS, Myelofibrosis, MF) [Phase 1, Phase 2]
A Phase 1/2 study of KB004 in myelodysplastic syndrome and myelofibrosis, sponsored by Humanigen, Inc., is currently suspended.
-
CLINICAL_TRIALS trial_result · 2015-11-13Clinical Trial Update: Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating a triple regimen of vorinostat, tacrolimus, and methotrexate to prevent graft-versus-host disease after allogeneic …
-
CLINICAL_TRIALS trial_result · 2015-11-05Clinical Trial Update: Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome [Phase 1]
Phase 1 study of PM01183 (lurbinectedin) in patients with acute leukemia and relapsed/refractory myelodysplastic syndrome has completed enro…
-
CLINICAL_TRIALS trial_result · 2015-10-28Clinical Trial Update: A Clinical Trial of Decitabine in Patients With Myelodysplastic Syndrome [Phase 1]
Phase 1 clinical trial of decitabine in patients with myelodysplastic syndrome has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-10-06Clinical Trial Update: Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation
This is an update on a completed trial assessing transplant-related mortality in patients undergoing peripheral blood stem cell transplantat…
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Outpatient Platelet Transfusions in Myelodysplastic Syndromes and Leukemia: The OPTIMAL Pilot [NA]
A pilot trial (OPTIMAL) evaluating outpatient platelet transfusions in patients with myelodysplastic syndromes and leukemia was terminated.